Cargando…

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer

N(6)‐methyladenosine (m(6)A) RNA modification, first discovered in 1974, is the most prevalent, abundant and penetrating messenger RNA (mRNA) modification in eukaryotes. This governs the fate of modified transcripts, regulates RNA metabolism and biological processes, and participates in pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Fu‐Chun, Zhu, Zhi‐Man, Pei, Dong‐Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653258/ https://www.ncbi.nlm.nih.gov/pubmed/33029866 http://dx.doi.org/10.1111/cpr.12921

Ejemplares similares

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

Mechanism of RNA modification N6-methyladenosine in human cancer
por: Zhou, Zijian, et al.
Publicado: (2020)

Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020)

N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity
por: Zheng, Siyi, et al.
Publicado: (2022)

Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022)

The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
por: He, Cheng, et al.
Publicado: (2023)

N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
por: Jin, Huan, et al.
Publicado: (2019)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
por: Zhang, YanJun, et al.
Publicado: (2023)

Crosstalk between m6A modification and alternative splicing during cancer progression
por: Zhu, Zhi‐Man, et al.
Publicado: (2023)

Genetic Analyses Support the Contribution of mRNA N(6)-methyladenosine (m(6)A) Modification to Human Disease Heritability
por: Zhang, Zijie, et al.
Publicado: (2020)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

The RNA Modification N(6)-methyladenosine and Its Implications in Human Disease
por: Batista, Pedro J.
Publicado: (2017)

N(6)-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions
por: Zhang, Zeyu, et al.
Publicado: (2023)

Effects of N(6)-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
por: Zhu, Yong-fu, et al.
Publicado: (2022)

Structural Insights into N(6)-methyladenosine (m(6)A) Modification in the Transcriptome
por: Huang, Jinbo, et al.
Publicado: (2018)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications
por: Hu, Bin-bin, et al.
Publicado: (2019)

RNA N(6)-methyladenosine modification in cancers: current status and perspectives
por: Deng, Xiaolan, et al.
Publicado: (2018)

Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
por: Liang, Zhixian, et al.
Publicado: (2020)

Importance of N(6)-methyladenosine RNA modification in lung cancer (Review)
por: Wang, Yueyang, et al.
Publicado: (2021)

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
por: Xu, Xiaoxin, et al.
Publicado: (2023)

Emerging Perspectives of RNA N(6)-methyladenosine (m(6)A) Modification on Immunity and Autoimmune Diseases
por: Tang, Lipeng, et al.
Publicado: (2021)

Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment
por: Wang, Dan, et al.
Publicado: (2023)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

N(6)-methyladenosine RNA modification regulates photosynthesis during photodamage in plants
por: Zhang, Man, et al.
Publicado: (2022)

The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease
por: Cai, Teng, et al.
Publicado: (2022)

Role of N(6)-Methyladenosine RNA Modification in Cardiovascular Disease
por: Song, Dandan, et al.
Publicado: (2021)

Interaction between N(6)-methyladenosine (m(6)A) modification and noncoding RNAs in cancer
por: Chen, Yi, et al.
Publicado: (2020)

Roles of N(6)-methyladenosine (m(6)A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
por: Chen, Jiahua, et al.
Publicado: (2022)

Roles and implications of mRNA N(6) ‐methyladenosine in cancer
por: Zeng, Lingxing, et al.
Publicado: (2023)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
por: Zhang, Yi, et al.
Publicado: (2023)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_efed2uae7gfkahpasliuroa56p